- Home
- BFLY vs OCGN Comparison
BFLY vs OCGN Comparison
Compare BFLY & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFLY
- OCGN
- Stock Information
- Founded
- BFLY 2011
- OCGN 2013
- Country
- BFLY United States
- OCGN United States
- Employees
- BFLY N/A
- OCGN N/A
- Industry
- BFLY Medical Electronics
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BFLY Health Care
- OCGN Health Care
- Exchange
- BFLY Nasdaq
- OCGN Nasdaq
- Market Cap
- BFLY 347.4M
- OCGN 321.7M
- IPO Year
- BFLY N/A
- OCGN N/A
- Fundamental
- Price
- BFLY $2.13
- OCGN $1.60
- Analyst Decision
- BFLY Strong Buy
- OCGN Strong Buy
- Analyst Count
- BFLY 3
- OCGN 2
- Target Price
- BFLY $3.50
- OCGN $7.00
- AVG Volume (30 Days)
- BFLY 7.5M
- OCGN 7.8M
- Earning Date
- BFLY 10-31-2025
- OCGN 11-07-2025
- Dividend Yield
- BFLY N/A
- OCGN N/A
- EPS Growth
- BFLY N/A
- OCGN N/A
- EPS
- BFLY N/A
- OCGN N/A
- Revenue
- BFLY $87,521,000.00
- OCGN $4,754,000.00
- Revenue This Year
- BFLY $13.52
- OCGN N/A
- Revenue Next Year
- BFLY $19.47
- OCGN N/A
- P/E Ratio
- BFLY N/A
- OCGN N/A
- Revenue Growth
- BFLY 23.13
- OCGN N/A
- 52 Week Low
- BFLY $1.32
- OCGN $0.52
- 52 Week High
- BFLY $4.98
- OCGN $1.90
- Technical
- Relative Strength Index (RSI)
- BFLY 50.38
- OCGN 53.05
- Support Level
- BFLY $2.12
- OCGN $1.51
- Resistance Level
- BFLY $2.42
- OCGN $1.83
- Average True Range (ATR)
- BFLY 0.22
- OCGN 0.14
- MACD
- BFLY -0.03
- OCGN -0.03
- Stochastic Oscillator
- BFLY 28.11
- OCGN 30.00
About BFLY Butterfly Network Inc.
Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. The company enables the practical application of ultrasound information in the clinical workflow. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. With its small, handheld size, low cost, and simple user interface.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").